Works matching IS 03407004 AND DT 2001 AND VI 49 AND IP 12
Results: 6
Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 679, doi. 10.1007/s002620000162
- By:
- Publication type:
- Article
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 663, doi. 10.1007/s002620000157
- By:
- Publication type:
- Article
Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 641, doi. 10.1007/s002620000158
- By:
- Publication type:
- Article
CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 629, doi. 10.1007/s002620000148
- By:
- Publication type:
- Article
The self peptide annexin II (208–223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 671, doi. 10.1007/s002620000163
- By:
- Publication type:
- Article
A murine B cell lymphoma expressing human HER2/neu undergoes spontaneous tumor regression and elicits antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 49, n. 12, p. 649, doi. 10.1007/s002620000155
- By:
- Publication type:
- Article